Microfluidic devices and methods including porous polymer monoliths
US-9201069-B2 · Dec 1, 2015 · US
US9383356B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9383356-B2 |
| Application number | US-201314431555-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 27, 2013 |
| Priority date | Sep 27, 2012 |
| Publication date | Jul 5, 2016 |
| Grant date | Jul 5, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A particulate latex for high-sensitive agglutination assay that barely poses non-specific reactions and can readily prepare diagnostic reagents, and a reagent for agglutination assay including the particle are provided. A particulate latex for agglutination assay, including a first polymerizable monomer having a phenyl group, a second polymerizable monomer having a phenyl group and a salt of sulfonic acid, and a third polymerizable monomer represented by Formula (1): CH 2 ═CR 1 —COOCH 2 CH 2 O(PO 2 )OCH 2 CH 2 —N(CH 3 ) 3 (1) where R 1 represents a hydrogen atom or a methyl group, wherein the density of functional groups in the third polymerizable monomer represented by Formula (1) on the surface of the particulate latex is 0.003 to 0.05 μmol/m 2 .
Opening claim text (preview).
The invention claimed is: 1. A particulate latex for agglutination assay, comprising: a first polymerizable monomer having a phenyl group; a second polymerizable monomer having a phenyl group and a salt of sulfonic acid; and a third polymerizable monomer represented by Formula (1): CH 2 ═CR 1 —COOCH 2 CH 2 O(PO 2 )OCH 2 CH 2 —N(CH 3 ) 3 (1) where R 1 represents a hydrogen atom or a methyl group, wherein the density of functional groups of the third polymerizable monomer represented by Formula (1) on the surface of the particulate latex is 0.003 to 0.05 μmol/m 2 . 2. The particulate latex for agglutination assay according to claim 1 , wherein the first polymerizable monomer having the phenyl group is at least one monomer selected from the group consisting of styrene, o-methylstyrene, p-methylstyrene, p-chlorostyrene, and 4-vinylbenzoic acid. 3. The particulate latex for agglutination assay according to claim 1 or 2 , wherein the second polymerizable monomer having the phenyl group and the salt of sulfonic acid is at least one monomer selected from the group consisting of salts of styrenesulfonic acid, salts of divinylbenzene sulfonic acid, salts of o-methylstyrenesulfonic acid, and salts of p-methylstyrenesulfonic acid. 4. The particulate latex for agglutination assay according to claim 1 , wherein the first polymerizable monomer having the phenyl group is styrene, and the second polymerizable monomer having the phenyl group and the salt of sulfonic acid is sodium styrenesulfonate. 5. The particulate latex for agglutination assay according to claim 1 , wherein the particulate latex carries an antigen or an antibody through physical adsorption. 6. A reagent for agglutination assay comprising the particulate latex for agglutination assay according to claim 1 .
of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen · CPC title
Synthetic resin · CPC title
Polyesters; Polycarbonates · CPC title
the carrier being characterised by its particulate form · CPC title
Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.